As of Apr 17
| -0.40 / -1.05%|
The 2 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 50.50, with a high estimate of 55.00 and a low estimate of 46.00. The median estimate represents a +34.20% increase from the last price of 37.63.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.